In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 23rd, 2004 | 24 | Yes |
Popular Name: Ifenprodil Ifenprodil
Find On: PubMed — Wikipedia — Google
CAS Numbers: 23210-56-2 , 23210-58-4
23210-56-2; D08064; Ifenprodil (INN)
23210-58-4; Cerocral (TN); D01445; Ifenprodil tartrate (JP16)
23210-58-4; Ifenprodil tartrate; Prestwick_623
4-(2-(4-Benzylpiperidin-1-yl)-1-hydroxypropyl)phenol
4-[1-hydroxy-2-[4-(phenylmethyl)piperidin-1-yl]propyl]phenol
CPD000449296; Ifenprodil; SAM001246980
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.58 | 7.91 | -39.49 | 3 | 3 | 1 | 45 | 326.46 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 99% | Fluorochem |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 100657; .5 water; .5 tartaric acid | NIH Clinical Collection via PubChem |
Target | NMDAR | Selleck Chemicals |
Target | Others | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 100657; SALT: .5 water; .5 tartaric acid | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT1A-1-E | Serotonin 1a (5-HT1a) Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 238 | 0.39 | Binding ≤ 10μM |
5HT2A-1-E | Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 610 | 0.36 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 110 | 0.41 | Binding ≤ 10μM |
HRH1-2-E | Histamine H1 Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1000 | 0.35 | Binding ≤ 10μM |
KCNH2-5-E | HERG (cluster #5 Of 5), Eukaryotic | Eukaryotes | 100 | 0.41 | Binding ≤ 10μM |
NMD3A-3-E | Glutamate [NMDA] Receptor Subunit 3A (cluster #3 Of 6), Eukaryotic | Eukaryotes | 13 | 0.46 | Binding ≤ 10μM |
NMD3B-3-E | Glutamate [NMDA] Receptor Subunit 3B (cluster #3 Of 6), Eukaryotic | Eukaryotes | 13 | 0.46 | Binding ≤ 10μM |
NMDE1-2-E | Glutamate [NMDA] Receptor Subunit Epsilon 1 (cluster #2 Of 5), Eukaryotic | Eukaryotes | 13 | 0.46 | Binding ≤ 10μM |
NMDE2-1-E | Glutamate [NMDA] Receptor Subunit Epsilon 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 94 | 0.41 | Binding ≤ 10μM |
NMDE3-1-E | Glutamate [NMDA] Receptor Subunit Epsilon 3 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 13 | 0.46 | Binding ≤ 10μM |
NMDE4-3-E | Glutamate [NMDA] Receptor Subunit Epsilon 4 (cluster #3 Of 6), Eukaryotic | Eukaryotes | 13 | 0.46 | Binding ≤ 10μM |
NMDZ1-2-E | Glutamate (NMDA) Receptor Subunit Zeta 1 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 13 | 0.46 | Binding ≤ 10μM |
SGMR1-1-E | Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 4 | 0.49 | Binding ≤ 10μM |
NMDE2-1-E | Glutamate [NMDA] Receptor Subunit Epsilon 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 110 | 0.41 | Functional ≤ 10μM |
NMDE3-2-E | Glutamate [NMDA] Receptor Subunit Epsilon 3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 263 | 0.38 | Functional ≤ 10μM |
NMDZ1-2-E | Glutamate (NMDA) Receptor Subunit Zeta 1 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 110 | 0.41 | Functional ≤ 10μM |
Z104304-1-O | Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other | Other | 220 | 0.39 | Binding ≤ 10μM |
Z104297-1-O | Glutamate NMDA Receptor; GRIN1/GRIN2B (cluster #1 Of 1), Other | Other | 66 | 0.42 | Functional ≤ 10μM |
Z104302-1-O | Glutamate NMDA Receptor (cluster #1 Of 3), Other | Other | 263 | 0.38 | Functional ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 3981 | 0.32 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 100 | 0.41 | Binding ≤ 1μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 110 | 0.41 | Binding ≤ 1μM |
NMDZ1_HUMAN | Q05586 | Glutamate (NMDA) Receptor Subunit Zeta 1, Human | 13 | 0.46 | Binding ≤ 1μM |
NMDZ1_RAT | P35439 | Glutamate (NMDA) Receptor Subunit Zeta 1, Rat | 13 | 0.46 | Binding ≤ 1μM |
NMD3A_RAT | Q9R1M7 | Glutamate [NMDA] Receptor Subunit 3A, Rat | 13 | 0.46 | Binding ≤ 1μM |
NMD3A_HUMAN | Q8TCU5 | Glutamate [NMDA] Receptor Subunit 3A, Human | 13 | 0.46 | Binding ≤ 1μM |
NMD3B_RAT | Q8VHN2 | Glutamate [NMDA] Receptor Subunit 3B, Rat | 13 | 0.46 | Binding ≤ 1μM |
NMD3B_HUMAN | O60391 | Glutamate [NMDA] Receptor Subunit 3B, Human | 13 | 0.46 | Binding ≤ 1μM |
NMDE1_HUMAN | Q12879 | Glutamate [NMDA] Receptor Subunit Epsilon 1, Human | 13 | 0.46 | Binding ≤ 1μM |
NMDE2_HUMAN | Q13224 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Human | 13 | 0.46 | Binding ≤ 1μM |
NMDE2_RAT | Q00960 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Rat | 13 | 0.46 | Binding ≤ 1μM |
NMDE3_HUMAN | Q14957 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Human | 13 | 0.46 | Binding ≤ 1μM |
NMDE4_HUMAN | O15399 | Glutamate [NMDA] Receptor Subunit Epsilon 4, Human | 13 | 0.46 | Binding ≤ 1μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 100 | 0.41 | Binding ≤ 1μM |
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 1000 | 0.35 | Binding ≤ 1μM |
5HT1A_MOUSE | Q64264 | Serotonin 1a (5-HT1a) Receptor, Mouse | 238 | 0.39 | Binding ≤ 1μM |
5HT2A_BOVIN | Q75Z89 | Serotonin 2a (5-HT2a) Receptor, Bovin | 610 | 0.36 | Binding ≤ 1μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 3.9 | 0.49 | Binding ≤ 1μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 100 | 0.41 | Binding ≤ 10μM |
ADA2A_RAT | P22909 | Alpha-2a Adrenergic Receptor, Rat | 110 | 0.41 | Binding ≤ 10μM |
NMDZ1_HUMAN | Q05586 | Glutamate (NMDA) Receptor Subunit Zeta 1, Human | 13 | 0.46 | Binding ≤ 10μM |
NMDZ1_RAT | P35439 | Glutamate (NMDA) Receptor Subunit Zeta 1, Rat | 13 | 0.46 | Binding ≤ 10μM |
NMD3A_RAT | Q9R1M7 | Glutamate [NMDA] Receptor Subunit 3A, Rat | 13 | 0.46 | Binding ≤ 10μM |
NMD3A_HUMAN | Q8TCU5 | Glutamate [NMDA] Receptor Subunit 3A, Human | 13 | 0.46 | Binding ≤ 10μM |
NMD3B_RAT | Q8VHN2 | Glutamate [NMDA] Receptor Subunit 3B, Rat | 13 | 0.46 | Binding ≤ 10μM |
NMD3B_HUMAN | O60391 | Glutamate [NMDA] Receptor Subunit 3B, Human | 13 | 0.46 | Binding ≤ 10μM |
NMDE1_HUMAN | Q12879 | Glutamate [NMDA] Receptor Subunit Epsilon 1, Human | 13 | 0.46 | Binding ≤ 10μM |
NMDE2_RAT | Q00960 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Rat | 13 | 0.46 | Binding ≤ 10μM |
NMDE2_HUMAN | Q13224 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Human | 13 | 0.46 | Binding ≤ 10μM |
NMDE3_HUMAN | Q14957 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Human | 13 | 0.46 | Binding ≤ 10μM |
NMDE4_HUMAN | O15399 | Glutamate [NMDA] Receptor Subunit Epsilon 4, Human | 13 | 0.46 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 100 | 0.41 | Binding ≤ 10μM |
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 1000 | 0.35 | Binding ≤ 10μM |
5HT1A_MOUSE | Q64264 | Serotonin 1a (5-HT1a) Receptor, Mouse | 238 | 0.39 | Binding ≤ 10μM |
5HT2A_BOVIN | Q75Z89 | Serotonin 2a (5-HT2a) Receptor, Bovin | 610 | 0.36 | Binding ≤ 10μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 3.9 | 0.49 | Binding ≤ 10μM |
NMDZ1_RAT | P35439 | Glutamate (NMDA) Receptor Subunit Zeta 1, Rat | 110 | 0.41 | Functional ≤ 10μM |
Z104302 | Z104302 | Glutamate NMDA Receptor | 110 | 0.41 | Functional ≤ 10μM |
Z104297 | Z104297 | Glutamate NMDA Receptor; GRIN1/GRIN2B | 177.4 | 0.39 | Functional ≤ 10μM |
NMDE2_RAT | Q00960 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Rat | 110 | 0.41 | Functional ≤ 10μM |
NMDE3_RAT | Q00961 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Rat | 263 | 0.38 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 2511.88643 | 0.33 | Functional ≤ 10μM |
Description | Species |
---|---|
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
CREB phosphorylation through the activation of CaMKII | |
EPHB-mediated forward signaling | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (z) signalling events | |
Histamine receptors | |
Ras activation uopn Ca2+ infux through NMDA receptor | |
Serotonin receptors | |
Unblocking of NMDA receptor, glutamate binding and activation | |
Voltage gated Potassium channels |